ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.32093G>A (p.Arg10698Gln)

gnomAD frequency: 0.00039  dbSNP: rs200161147
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000223128 SCV000272625 uncertain significance not specified 2015-05-18 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The p.Arg9454Gln va riant in TTN has not been previously reported in individuals with cardiomyopathy , but has been identified in 0.1% (19/16434) of South Asian chromosomes by the E xome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs20016 1147). Arginine (Arg) at position 9454 is not conserved in mammals or evolutiona rily distant species and 1 mammal (weddell seal) carries a glutamine (Gln) at th is position, raising the possibility that this change may be tolerated. In addit ion, this variant is located in the last three bases of the exon, which is part of the 5? splice region. Computational tools do not suggest an impact to splicin g. However, this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the p.Arg9454Gln variant is unce rtain, it's frequency and the presence of the variant amino acid in another mamm al suggest it is more likely to be benign.
Invitae RCV001080545 SCV000642980 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-28 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000184445 SCV000701346 uncertain significance not provided 2018-02-13 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000768884 SCV000900257 uncertain significance Cardiomyopathy 2017-03-21 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000223128 SCV001880240 likely benign not specified 2021-03-22 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000184445 SCV004152488 likely benign not provided 2023-09-01 criteria provided, single submitter clinical testing TTN: BP4
PreventionGenetics, part of Exact Sciences RCV003895218 SCV004717208 uncertain significance TTN-related condition 2023-10-28 criteria provided, single submitter clinical testing The TTN c.32093G>A variant is predicted to result in the amino acid substitution p.Arg10698Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.11% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179553782-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
GeneDx RCV000184445 SCV000237077 not provided not provided 2014-04-14 no assertion provided clinical testing Missense variants in the TTN gene are considered 'unclassified' if they are not previously reported in the literature and do not have >1% frequency in the population to be considered a polymorphism. Research indicates that truncating mutations in the TTN gene are expected to account for approximately 25% of familial and 18% of sporadic idiopathic DCM; however, truncating variants in the TTN gene have been reported in approximately 3% of reported control alleles. There has been little investigation into non-truncating variants. (Herman D et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 366:619-628, 2012) The variant is found in DCM-CRDM panel(s).
Clinical Genetics, Academic Medical Center RCV000184445 SCV001919831 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000184445 SCV001958092 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.